Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,727Revenue $M512Net Margin (%)19.8Z-Score8.4
Enterprise Value $M1,337EPS $1.5Operating Margin %-1.3F-Score5
P/E(ttm))905Cash Flow Per Share $1.3Pre-tax Margin (%)28.7Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %0Quick Ratio4.7Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %4.1Current Ratio5.3Lower Leverage y-yY
Price/Cash Flow16.5y-y EBITDA Growth Rate %-88.8ROA % (ttm)10.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)12.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M70.1ROI % (ttm)18.6Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLJohn Hussman 2014-06-30 Add0.21%$23.6 - $30.68
($26.93)
$ 24.43-9%Add 40.91%310,000
IPXLJohn Hussman 2014-03-31 Buy 0.44%$22.02 - $27.91
($24.94)
$ 24.43-2%New holding, 220000 sh.220,000
IPXLJohn Hussman 2012-03-31 Sold Out -0.11%$18.64 - $24.37
($20.72)
$ 24.4318%Sold Out0
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 24.4318%Sold Out0
IPXLJoel Greenblatt 2011-12-31 Reduce-0.47%$16.53 - $20.75
($18.65)
$ 24.4331%Reduce -88.51%21,057
IPXLJoel Greenblatt 2011-09-30 Reduce-0.38%$15.26 - $21.56
($19.54)
$ 24.4325%Reduce -40.22%183,187
IPXLJoel Greenblatt 2011-06-30 Add0.76%$20.21 - $28.73
($25.28)
$ 24.43-3%Add 446.09%306,452
IPXLGeorge Soros 2011-06-30 Sold Out $20.21 - $28.73
($25.28)
$ 24.43-3%Sold Out0
IPXLJohn Hussman 2011-03-31 Add0.02%$20.11 - $25.52
($22.84)
$ 24.437%Add 20.21%339,000
IPXLGeorge Soros 2011-03-31 Reduce$20.11 - $25.52
($22.84)
$ 24.437%Reduce -41.13%13,600
IPXLJoel Greenblatt 2011-03-31 Reduce-1.55%$20.11 - $25.52
($22.84)
$ 24.437%Reduce -78.32%56,118
IPXLJoel Greenblatt 2010-12-31 Buy 1.7%$17.91 - $21.86
($19.9)
$ 24.4323%New holding, 258801 sh.258,801
IPXLJohn Hussman 2010-12-31 Add0.06%$17.91 - $21.86
($19.9)
$ 24.4323%Add 176.47%282,000
IPXLGeorge Soros 2010-12-31 Buy 0.01%$17.91 - $21.86
($19.9)
$ 24.4323%New holding, 23100 sh.23,100
IPXLJohn Hussman 2010-09-30 Buy 0.03%$15.63 - $19.79
($17.38)
$ 24.4341%New holding, 102000 sh.102,000
IPXLGeorge Soros 2010-06-30 Sold Out $16.66 - $21.62
($19.29)
$ 24.4327%Sold Out0
IPXLGeorge Soros 2010-03-31 Buy $13 - $18.05
($14.93)
$ 24.4364%New holding, 17400 sh.17,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
IPXL John Hussman 2014-06-30310,0000.440.71+40.91%
Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HSU LARRYDirector 2014-06-06Sell100,000$28.38-13.92view
TERRERI PETER RDirector 2014-05-27Sell3,000$28-12.75view
HSU LARRYDirector 2014-05-22Sell50,000$27.22-10.25view
HSU LARRYDirector 2014-05-21Sell3,800$26.53-7.92view
TERRERI PETER RDirector 2014-05-20Sell666$26.07-6.29view
TERRERI PETER RDirector 2014-05-19Sell950$26.03-6.15view
FLEMING NIGELDirector 2014-05-16Sell1,900$25.72-5.02view
TERRERI PETER RDirector 2014-05-13Sell666$26.7-8.5view
FLEMING NIGELDirector 2014-05-12Sell1,333$26.58-8.09view
MARKBREITER MICHAELDirector 2014-05-08Sell12,500$26.44-7.6view

Press Releases about IPXL :

    Quarterly/Annual Reports about IPXL:

    News about IPXL:

    Articles On GuruFocus.com
    comment on IPXL Sep 24 2012 
    President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 
    Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 5,000 Shares Aug 12 2010 
    Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 10,000 Shares Aug 12 2010 
    Impax Laboratories Reports Second Quarter 2009 Financial Results Aug 04 2009 

    More From Other Websites
    Attention Impax Laboratories, Inc. Investors: Impax Misled Investors According to a Recently Filed... Aug 19 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Aug 18 2014
    EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Against Impax... Aug 15 2014
    IMPAX LABORATORIES INC Financials Aug 15 2014
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Impax... Aug 15 2014
    Pomerantz Law Firm Announces the Filing of a Class Action Against Impax Laboratories, Inc. and... Aug 13 2014
    SHAREHOLDER ALERT: Investigation on Behalf of Impax Laboratories, Inc. Investors Announced by Law... Aug 11 2014
    Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks... Aug 08 2014
    Impax Laboratories Inc Stock Upgraded (IPXL) Aug 08 2014
    Impax's Second Quarter 2014 Revenues Increased 45% to $188.1 Million Aug 06 2014
    IMPAX LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 06 2014
    Impax's Second Quarter 2014 Revenues Increased 45% to $188.1 Million Aug 06 2014
    Q2 2014 Impax Laboratories Earnings Release - Before Market Open Aug 06 2014
    FDA Performs Inspection of Impax's Hayward Facility Aug 04 2014
    IMPAX LABORATORIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 04 2014
    FDA Performs Inspection of Impax's Hayward Facility Aug 04 2014
    Impax Shares Plunge Post FDA Inspection of Taiwan Facility Jul 31 2014
    SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible... Jul 30 2014
    INVESTOR ALERT: Investigation of Impax Laboratories, Inc. Announced by Glancy Binkow & Goldberg LLP Jul 29 2014
    Impax Labs shares slump after FDA inspection Jul 29 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide